- AU$16.30m
- AU$14.56m
- AU$3.77m
Appendix 4C - quarterly
PRE_NR Ends: 08:21:35
PainChek rises on getting regulatory approvals in UK, Australia
Brief: Painchek Receives CE Mark And TGA Clearance For Universal App
PRE_NR Ends: 08:32:40
PainChek receives CE Mark & TGA clearance for Universal App
PainChek to present at NWR Virtual Investor Conference
Appendix 3G
S&P DJI Announces March 2021 Quarterly Rebalance
PRE_NR Ends: 17:13:42
PRE_NR Ends: 19:46:50
Appendix 4D & Financial Statements
Response to ASX Price Query
PRE_NR Ends: 10:03:26
Brief: Painchek Says Exploring New Entry Into SE Asia, Among Others In 2021 For Residential Aged Care
979k R&D Tax Incentive Received
Results of Meeting
AGM Presentation
Appendix 3G